The specialty pharmacy market is particularly ripe for opportunity. We’ve seen increased merger and acquisition activity in this health care sector, with consistently high valuations, as a variety of different candidates look for acquisition opportunities, including large retail pharmacy chains and big-box retailers looking to expand their holdings. Private equity investors have also been active in the market, while a number of other private equity sellers have been the beneficiaries of this robust market, as they sell their specialty pharmacy portfolio companies at attractive valuations. Our latest piece for Law360 discusses this sector more fully.
View the Law360 column “Specialty Pharmacy Market Ripe For Private Equity Buyers” (account required for access).
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
